Pacira BioSciences Inc (NAS:PCRX)
$ 16.81 -0.7 (-4%) Market Cap: 776.17 Mil Enterprise Value: 998.18 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 72/100

Pacira Biosciences Inc Investor Day Transcript

Oct 15, 2021 / 12:00PM GMT
Release Date Price: $53.2 (-1.19%)
David M. Stack
Pacira BioSciences, Inc. - Chairman & CEO

Good morning. For the folks that are here with us live, thanks for taking the time to join. For folks that are online, we're excited to share what we believe is a unique position of Pacira. Very few companies can provide opportunities to address both the COVID pandemic and the opioid epidemic, providing low or no opioid options to migrate procedures to the 23-hour sites of care, while hospital beds are being sequestered for COVID patients.

We have the standard -- not working? I'll do it -- so just standard disclosures and forward-looking statements. So we have a packed day, and so I'm going to jump right in. For those of you joining us on the web, if you exit full-screen mode, you'll find a Q&A portal on the right-hand side of the screen for you to enter your questions. We'll have a 20-minute question-and-answer period at the end of the presentations.

So I'm going to start out with a couple of slides that talk about the TAM for our currently marketed products and where we see the growth opportunities. So first, EXPAREL,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot